These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36823311)

  • 1. The tumor biological significance of RNF43 and LRP1B in gastric cancer is complex and context-dependent.
    Holm B; Barsuhn S; Behrens HM; Krüger S; Röcken C
    Sci Rep; 2023 Feb; 13(1):3191. PubMed ID: 36823311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of endogenous RNF43 function enhances proliferation and tumour growth of intestinal and gastric cells.
    Neumeyer V; Grandl M; Dietl A; Brutau-Abia A; Allgäuer M; Kalali B; Zhang Y; Pan KF; Steiger K; Vieth M; Anton M; Mejías-Luque R; Gerhard M
    Carcinogenesis; 2019 Jun; 40(4):551-559. PubMed ID: 30380024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of LDL receptor-related protein 1B in patients with gastric cancer.
    Yasufuku I; Saigo C; Kito Y; Yoshida K; Takeuchi T
    J Mol Histol; 2021 Apr; 52(2):165-172. PubMed ID: 33389427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent frameshift mutations in 2 mononucleotide repeats of RNF43 gene and its regional heterogeneity in gastric and colorectal cancers.
    Jo YS; Kim MS; Lee JH; Lee SH; An CH; Yoo NJ
    Hum Pathol; 2015 Nov; 46(11):1640-6. PubMed ID: 26297255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of RNF43 Function Contributes to Gastric Carcinogenesis by Impairing DNA Damage Response.
    Neumeyer V; Brutau-Abia A; Allgäuer M; Pfarr N; Weichert W; Falkeis-Veits C; Kremmer E; Vieth M; Gerhard M; Mejías-Luque R
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):1071-1094. PubMed ID: 33188943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ring finger protein 43 associates with gastric cancer progression and attenuates the stemness of gastric cancer stem-like cells via the Wnt-β/catenin signaling pathway.
    Gao Y; Cai A; Xi H; Li J; Xu W; Zhang Y; Zhang K; Cui J; Wu X; Wei B; Chen L
    Stem Cell Res Ther; 2017 Apr; 8(1):98. PubMed ID: 28446252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study.
    Kim KW; Kim N; Choi Y; Kim WS; Yoon H; Shin CM; Park YS; Lee DH; Park YS; Ahn SH; Park DJ; Kim HH; Lee HS; Kim JW; Kim JW; Lee KW; Chang W; Park JH; Lee YJ; Lee KH; Kim YH
    Gastric Cancer; 2021 Jul; 24(4):844-857. PubMed ID: 33598811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer.
    Matsumoto A; Shimada Y; Nakano M; Oyanagi H; Tajima Y; Nakano M; Kameyama H; Hirose Y; Ichikawa H; Nagahashi M; Nogami H; Maruyama S; Takii Y; Ling Y; Okuda S; Wakai T
    Oncol Rep; 2020 Jun; 43(6):1853-1862. PubMed ID: 32236609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer.
    Hyun CL; Park SJ; Kim HS; Song HJ; Kim HU; Lee C; Lee DH; Maeng YH; Kim YS; Jang B
    Anticancer Res; 2021 Jul; 41(7):3689-3698. PubMed ID: 34230168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of the Tumour Biological Significance of PCLO in Gastric Cancer: Results from a Large Central European Cohort.
    Bernhardt M; Behrens HM; Krüger S; Röcken C
    Pathobiology; 2024; 91(3):187-195. PubMed ID: 37935138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of loss-of-function mutations at the RNF43 locus on colorectal cancer development and progression.
    Eto T; Miyake K; Nosho K; Ohmuraya M; Imamura Y; Arima K; Kanno S; Fu L; Kiyozumi Y; Izumi D; Sugihara H; Hiyoshi Y; Miyamoto Y; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Furukawa T; Araki K; Baba H; Ishimoto T
    J Pathol; 2018 Aug; 245(4):445-455. PubMed ID: 29756208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohort.
    Schrumpf T; Behrens HM; Haag J; Krüger S; Röcken C
    PLoS One; 2022; 17(2):e0264011. PubMed ID: 35167603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
    Jang BG; Lee BL; Kim WH
    Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants.
    Thornton AM; Fang L; Lo A; McSharry M; Haan D; O'Brien C; Berger AH; Giannakis M; Brooks AN
    PLoS Comput Biol; 2021 Jul; 17(7):e1009132. PubMed ID: 34214079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated Wnt signalling and recurrent mutations of the tumour suppressor RNF43 in early gastric carcinogenesis.
    Min BH; Hwang J; Kim NK; Park G; Kang SY; Ahn S; Ahn S; Ha SY; Lee YK; Kushima R; Van Vrancken M; Kim MJ; Park C; Park HY; Chae J; Jang SS; Kim SJ; Kim YH; Kim JI; Kim KM
    J Pathol; 2016 Nov; 240(3):304-314. PubMed ID: 27514024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort.
    Schoop I; Maleki SS; Behrens HM; Krüger S; Haag J; Röcken C
    Hum Pathol; 2020 Nov; 105():53-66. PubMed ID: 32971129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and clinical significance of lymph node metastasis-related genes within esophagogastric junction adenocarcinoma.
    Han R; Chen G; Li M; Peng ZM; Xu L
    Cancer Med; 2021 Aug; 10(15):5088-5100. PubMed ID: 34152098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference.
    Ulase D; Heckl S; Behrens HM; Krüger S; Röcken C
    Histopathology; 2020 Feb; 76(3):433-446. PubMed ID: 31538348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease associated domain of RNF43 is not necessary for the suppression of Wnt/β-catenin signaling in human cells.
    Radaszkiewicz T; Bryja V
    Cell Commun Signal; 2020 Jun; 18(1):91. PubMed ID: 32527265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study.
    Dottermusch M; Krüger S; Behrens HM; Halske C; Röcken C
    Virchows Arch; 2019 Nov; 475(5):563-571. PubMed ID: 31332522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.